HOUSTON, Sept. 4, 2024 /PRNewswire/ -- Constantiam Biosciences, a startup focused on powering genomic medicine, is pleased to announce that it has been awarded a $2.05 million Phase II Small Business ...

WATERTOWN, Mass. and CINCINNATI, June 18, 2026 (GLOBE NEWSWIRE) -- Constantiam Biosciences and Cincinnati Children's today announced a strategic collaboration through an exclusive option for future ...

HOUSTON, TX, UNITED STATES, October 29, 2024 /EINPresswire.com/ -- Constantiam Biosciences, a biotechnology startup specializing in high-throughput experimentation ...

With MAVEvidence, we're advancing genetic variant interpretation, empowering clinicians to accurately assess Alzheimer's and dementia risks for early personalized detection and precision care.” - ...

Constantiam Biosciences Inc. and Cincinnati Children’s have established a strategic collaboration, through an exclusive option for future licensing rights, to advance first-in-class small-molecule ...